MedPath
FDA Approval

Sandostatin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
November 3, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Octreotide(500 ug in 1 mL)

Products3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sandostatin

Product Details

NDC Product Code
0078-0182
Application Number
NDA019667
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS, SUBCUTANEOUS
Effective Date
November 3, 2023
LACTIC ACIDInactive
Code: 33X04XA5ATClass: IACTQuantity: 3.4 mg in 1 mL
SODIUM BICARBONATEInactive
Code: 8MDF5V39QOClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
Code: 75R0U2568IClass: ACTIMQuantity: 500 ug in 1 mL
MANNITOLInactive
Code: 3OWL53L36AClass: IACTQuantity: 45 mg in 1 mL

Sandostatin

Product Details

NDC Product Code
0078-0181
Application Number
NDA019667
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS, SUBCUTANEOUS
Effective Date
November 3, 2023
Code: 75R0U2568IClass: ACTIMQuantity: 100 ug in 1 mL
MANNITOLInactive
Code: 3OWL53L36AClass: IACTQuantity: 45 mg in 1 mL
LACTIC ACIDInactive
Code: 33X04XA5ATClass: IACTQuantity: 3.4 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM BICARBONATEInactive
Code: 8MDF5V39QOClass: IACT

Sandostatin

Product Details

NDC Product Code
0078-0180
Application Number
NDA019667
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS, SUBCUTANEOUS
Effective Date
November 3, 2023
Code: 75R0U2568IClass: ACTIMQuantity: 50 ug in 1 mL
LACTIC ACIDInactive
Code: 33X04XA5ATClass: IACTQuantity: 3.4 mg in 1 mL
MANNITOLInactive
Code: 3OWL53L36AClass: IACTQuantity: 45 mg in 1 mL
SODIUM BICARBONATEInactive
Code: 8MDF5V39QOClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath